125 related articles for article (PubMed ID: 1767046)
1. [Dynamic imaging with magnetic resonance in the diagnosis of breast disease].
Ercolani P; Giovagnoni A; Giuseppetti G; Baldassarre S; De Nigris E; Amici F
Radiol Med; 1991 Oct; 82(4):422-6. PubMed ID: 1767046
[TBL] [Abstract][Full Text] [Related]
2. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
[TBL] [Abstract][Full Text] [Related]
3. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
5. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative dynamic contrast breast-MRI with the 0.5 tesla equipment].
Klengel S; Hietschold V; Schreiber M; Köhler K
Rontgenpraxis; 1994 Aug; 47(8):223-8. PubMed ID: 7974011
[No Abstract] [Full Text] [Related]
7. [Magnetic resonance tomography (MRT) of the breast in problem patients].
Brezina A; Schwaighofer BW
Wien Klin Wochenschr; 1994; 106(18):584-9. PubMed ID: 7992497
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
Hamm B; Laniado M; Saini S
Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
[TBL] [Abstract][Full Text] [Related]
9. [MR imaging for breast cancer].
Seki T; Hachiya J; Nitatori T; Yokoyama K; Fukushima H; Uchigasaki S
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):347-56. PubMed ID: 8709936
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance tomography of the breast. The results of 253 examinations].
Kaiser WA
Dtsch Med Wochenschr; 1989 Sep; 114(36):1351-7. PubMed ID: 2776660
[TBL] [Abstract][Full Text] [Related]
11. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
[TBL] [Abstract][Full Text] [Related]
12. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced MR imaging of breast lesions and effect on treatment.
Schelfout K; Van Goethem M; Kersschot E; Colpaert C; Schelfhout AM; Leyman P; Verslegers I; Biltjes I; Van Den Haute J; Gillardin JP; Tjalma W; Van Der Auwera JC; Buytaert P; De Schepper A
Eur J Surg Oncol; 2004 Jun; 30(5):501-7. PubMed ID: 15135477
[TBL] [Abstract][Full Text] [Related]
14. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
[TBL] [Abstract][Full Text] [Related]
15. [Technics for the preoperative marking of nonpalpable breast lesions in MRT].
Sittek H; Kessler M; Müller-Lisse U; Untch M; Bohmert H; Reiser M
Rofo; 1996 Jul; 165(1):84-7. PubMed ID: 8765369
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer.
Kono M; Adachi S; Kusumoto M; Sakai E
J Thorac Imaging; 1993; 8(1):18-26. PubMed ID: 8418316
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging.
Kneeshaw PJ; Lowry M; Manton D; Hubbard A; Drew PJ; Turnbull LW
Breast; 2006 Feb; 15(1):29-38. PubMed ID: 16002292
[TBL] [Abstract][Full Text] [Related]
19. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
Torricelli P; Montanari N; De Santis M; Pollastri C
Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
[TBL] [Abstract][Full Text] [Related]
20. [MR mammography in patients at risk].
Kaiser WA; Mittelmeier O
Rofo; 1992 Jun; 156(6):576-81. PubMed ID: 1617179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
